Roberta R.
- Country
- Italy
- Department
- Neuro-oncology
Research Overview
- Evaluation of SonoCloud-9 with Carboplatin Versus Lomustine or Temozolomide in First Recurrence Glioblastoma Post-Resection: A Randomized, Open-Label Trial
- Phase II Multicenter Randomized Study of Regorafenib in Recurrent Grade 2 and 3 Meningioma Post-Surgery and Radiotherapy
- Phase II Randomized Study of [177Lu]Lu-DOTATATE in Recurrent Meningioma Lacking Surgical or Radiotherapeutic Options
Data & Insights
Has run more than one trial at 44 of 101 partner sites.
Specializations
Neuro-Oncology: Meningioma Research
Specializes in the treatment of high-grade meningiomas, with particular focus on therapeutic approaches for grade 2 and grade 3 meningiomas in cases where conventional treatments have proven insufficient.
- Progressive Meningioma Management
- Post-surgical Recurrence
- Advanced Treatment Protocols
Glioma Treatment Innovation
Focuses on developing targeted therapies for IDH-mutant gliomas and glioblastoma, with specific attention to genetic markers and molecular characteristics that influence treatment response.
- IDH1 and IDH2 Mutations
- MGMT Methylation Status
- Novel Therapeutic Combinations
Advanced Brain Cancer Therapeutics
Investigates innovative treatment approaches for newly diagnosed and recurrent glioblastoma, incorporating tumor-treating fields and exploring breakthrough therapeutic combinations.
- Blood-Brain Barrier Modulation
- Multimodal Treatment Strategies
- Chemotherapy Optimization
Related Investigators
Researchers in similar fields or departments
Want to know more about this investigator?
We can share extended profile information and contact details.
Is something out of date?
Tell us what needs correcting and we'll update this profile.